Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
February 1, 2020
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study
N-S Schmidt-Hegemann, S G C Kroeze, C Henkenberens, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial
S Peters, E Felip, U Dafni, et al.
Clinical and Translational Radiation Oncology
|
April 8, 2024
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter <i>SMILE</i> phase II trial
C A Fink, J Ristau, C Buchele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2019
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
T Eder, A K Hess, R Konschak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 9, 2022
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG)
D Martin, T Schreckenbach, P Ziegler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2016
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
I Tinhofer, V Budach, M Saki, et al.
ESMO Open
|
November 29, 2021
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck
B Keam, J-P Machiels, H R Kim, et al.
World Journal of Urology
|
February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
A Karl, A Buchner, C Tympner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
E S M van Aken, B Devnani, A Prelaj, et al.
World Journal of Urology
|
February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
A Karl, A Buchner, C Tympner, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
European Journal of Nuclear Medicine and Molecular Imaging
|
February 1, 2020
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study
N-S Schmidt-Hegemann, S G C Kroeze, C Henkenberens, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial
S Peters, E Felip, U Dafni, et al.
Clinical and Translational Radiation Oncology
|
April 8, 2024
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter <i>SMILE</i> phase II trial
C A Fink, J Ristau, C Buchele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2019
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group
T Eder, A K Hess, R Konschak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 9, 2022
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG)
D Martin, T Schreckenbach, P Ziegler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2016
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
I Tinhofer, V Budach, M Saki, et al.
ESMO Open
|
November 29, 2021
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck
B Keam, J-P Machiels, H R Kim, et al.
World Journal of Urology
|
February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
A Karl, A Buchner, C Tympner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
E S M van Aken, B Devnani, A Prelaj, et al.
World Journal of Urology
|
February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
A Karl, A Buchner, C Tympner, et al.
Page
of 12